Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in New York City. The summit provided the opportunity to engage in face-to-face discussions with leading stakeholders on the best practices to enhance global protections for patent portfolios. Now more than ever in these increasingly […]
Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature.
Rasa’s research thesis, titled, Re-engineering the function of natural killer cell receptors via CRISPR/Cas9: a new approach for ‘off the shelf’ immunotherapy, investigated the generation of Natural Killer (NK) cells (immune cells) from gene-edited stem cells to provide an ‘off-the-shelf’ supply for […]
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th CIMT Annual Meeting in Germany.
CIMT is Europe’s largest meeting focused on cancer immunotherapy research and development. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As […]
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley just over an hour from Melbourne, the venue provided a relaxing escape for the Cartherics team to engage, connect and grow as individuals and a team.
We heard from motivational speakers, took part in a personal […]
Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in ovarian cancer research at the European Society for Medical Oncology Targeted Anticancer Therapies Congress, ESMO TAT 2023, in Paris this March.
ESMO TAT, known as “The Home of Phase I in Oncology”, is the leading […]
Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown Promenade, Melbourne.
The Australia Biologics Festival 2023 is Australia’s premier conference that aims to gather the innovators, pioneers, leaders in the biologics fraternity including biologics, biosimilars, vaccines, cell and gene therapy (CGT) and evolving therapeutics […]
Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature.
Saleh’s research thesis, ‘The role of integrin linked kinase in senescence and immunosuppressive tumor microenvironment in colon cancer’, identified that integrin-linked kinase (ILK) is associated with cancer prognosis and characterises the immunosuppressive tumor microenvironment. These findings suggest possible clinical avenues of targeting […]
By Leigh Dayton, 20 January 2022
Pollyanna Goh – Polly to her friends, family and colleagues – is a specialist’s specialist. For the past decade she has worked in the field of induced pluripotent stem cells (iPSCs). She was such an […]
Monash Grad Rachelle Duffin joins the team
1 March 2021
By Leigh Dayton
Fresh from a Research Assistant job at the Peter MacCallum Cancer Centre and a Bachelor of Science (Honours) from Monash University, Rachelle Duffin took up her new role at Cartherics at the beginning of February.
She’s “delighted and honoured” to be supervised by Cartherics […]
It all happened at Cape Schanck ……
By Leigh Dayton
24 February 2021
2020 was a rough year everywhere for everyone, including Cartherics’ hard-working team. By way of a thank you CEO Alan Trounson, Chairman Bob Moses and Chief Operating Officer Ian Nisbet hosted a company come-one come-all event this month at the Royal Automobile Club […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
